| High and low molecular weight hyaluronic acid differentially influence macrophage activation JE Rayahin, JS Buhrman, Y Zhang, TJ Koh, RA Gemeinhart ACS biomaterials science & engineering 1 (7), 481-493, 2015 | 602 | 2015 |
| Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models W Zhang, G Fulci, H Wakimoto, TA Cheema, JS Buhrman, DS Jeyaretna, ... Neoplasia 15 (6), 591-599, 2013 | 95 | 2013 |
| Establishing the lysine-rich protein CEST reporter gene as a CEST MR imaging detector for oncolytic virotherapy CT Farrar, JS Buhrman, G Liu, A Kleijn, MLM Lamfers, MT McMahon, ... Radiology 275 (3), 746-754, 2015 | 85 | 2015 |
| Markers are shared between adipogenic and osteogenic differentiated mesenchymal stem cells M Köllmer, JS Buhrman, Y Zhang, RA Gemeinhart Journal of developmental biology and tissue engineering 5 (2), 18, 2013 | 84 | 2013 |
| Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma W Zhang, G Fulci, JS Buhrman, AO Stemmer-Rachamimov, JW Chen, ... Molecular Therapy 20 (1), 37-45, 2012 | 78 | 2012 |
| Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells BJ Passer, P Castelo-Branco, JS Buhrman, S Varghese, SD Rabkin, ... Cancer gene therapy 16 (7), 551-560, 2009 | 51 | 2009 |
| Extended release of an anti–heparan sulfate peptide from a contact lens suppresses corneal herpes simplex virus-1 infection D Jaishankar, JS Buhrman, T Valyi-Nagy, RA Gemeinhart, D Shukla Investigative ophthalmology & visual science 57 (1), 169-180, 2016 | 40 | 2016 |
| Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging A Kleijn, JW Chen, JS Buhrman, GR Wojtkiewicz, Y Iwamoto, ML Lamfers, ... Clinical Cancer Research 17 (13), 4484-4493, 2011 | 40 | 2011 |
| Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer P Castelo-Branco, BJ Passer, JS Buhrman, S Antoszczyk, M Marinelli, ... Gene therapy 17 (6), 805-810, 2010 | 38 | 2010 |
| Arginine-rich, cell penetrating peptide–anti-microRNA complexes decrease glioblastoma migration potential Y Zhang, M Köllmer, JS Buhrman, MY Tang, RA Gemeinhart Peptides 58, 83-90, 2014 | 33 | 2014 |
| Reducible micelleplexes are stable systems for anti-miRNA delivery in cerebrospinal fluid Y Zhang, JS Buhrman, Y Liu, JE Rayahin, RA Gemeinhart Molecular pharmaceutics 13 (6), 1791-1799, 2016 | 30 | 2016 |
| Proteolytically activated anti-bacterial hydrogel microspheres JS Buhrman, LC Cook, JE Rayahin, MJ Federle, RA Gemeinhart Journal of Controlled Release 171 (3), 288-295, 2013 | 23 | 2013 |
| Melittin–glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity JE Rayahin, JS Buhrman, RA Gemeinhart European Journal of Pharmaceutical Sciences 65, 112-121, 2014 | 19 | 2014 |
| Active, soluble recombinant melittin purified by extracting insoluble lysate of Escherichia coli without denaturation JS Buhrman, JE Rayahin, LC Cook, MJ Federle, RA Gemeinhart Biotechnology progress 29 (5), 1150-1157, 2013 | 15 | 2013 |
| High and low molecular weight hyaluronic acid differentially influence macrophage activation, ACS Biomater. Sci. Eng. 1 (2015) 481–493 JE Rayahin, JS Buhrman, Y Zhang, TJ Koh, RA Gemeinhart | 14 | |
| In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins JS Buhrman, JE Rayahin, M Köllmer, RA Gemeinhart BMC biotechnology 12, 1-9, 2012 | 11 | 2012 |
| Hybrid nanocrystals: university of Kentucky US20060280680A1 JE Rayahin, JS Buhrman, RA Gemeinhart Expert opinion on therapeutic patents 22 (3), 341-348, 2012 | 8 | 2012 |
| Recombinant Protein Immobilization and Controlled-Release Mediated by a Non-Covalent Protein Anchor JS Buhrman University of Illinois Chicago, 2017 | 1 | 2017 |
| PCL19-114: Development of Locally Deliverable Polymeric Microspheres With Environmentally Specific Release for the Improvement of Cancer Therapy K Sokolowski, JS Buhrman, RA Gemeinhart Journal of the National Comprehensive Cancer Network 17 (3.5), PCL19-114 …, 2019 | | 2019 |
| Hydrogels for delivery of therapeutic polypeptides R Gemeinhart, J Buhrman, J Rayahin US Patent 9,457,101, 2016 | | 2016 |
